Advisors Asset Management Inc. Has $838,000 Stock Holdings in Tempus AI, Inc. $TEM

Key Points

• Advisors Asset Management Inc. significantly increased its stake in Tempus AI, Inc. by 753.9%, owning 17,377 shares valued at $838,000 at the end of the 1st quarter.
• Tempus AI reported earnings of ($0.22) per share, exceeding analysts' expectations, with revenue up 89.5% year-over-year to $314.64 million.
• Insiders have sold a total of 903,104 shares worth $63.7 million in the last three months, while insiders currently own 26.27% of the company's stock.

Advisors Asset Management Inc. increased its position in Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 753.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,377 shares of the company's stock after buying an additional 15,342 shares during the period. Advisors Asset Management Inc.'s holdings in Tempus AI were worth $838,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in TEM. Cherry Tree Wealth Management LLC acquired a new stake in shares of Tempus AI in the 1st quarter valued at about $31,000. University of Texas Texas AM Investment Management Co. acquired a new position in Tempus AI during the 1st quarter valued at about $33,000. Continuum Advisory LLC acquired a new position in Tempus AI during the 1st quarter valued at about $39,000. Bartlett & CO. Wealth Management LLC boosted its stake in Tempus AI by 100.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock valued at $39,000 after purchasing an additional 400 shares during the last quarter. Finally, Nemes Rush Group LLC acquired a new position in Tempus AI during the 1st quarter valued at about $39,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Tempus AI Price Performance

Shares of NASDAQ TEM opened at $81.01 on Wednesday. Tempus AI, Inc. has a twelve month low of $31.36 and a twelve month high of $91.45. The stock's 50 day moving average price is $66.15 and its 200-day moving average price is $59.16. The company has a market capitalization of $14.07 billion, a PE ratio of -68.08 and a beta of 5.08. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, topping analysts' consensus estimates of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The firm had revenue of $314.64 million for the quarter, compared to the consensus estimate of $296.84 million. During the same quarter in the previous year, the business earned ($6.86) EPS. The company's revenue was up 89.5% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. On average, equities analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current year.

Insider Buying and Selling

In related news, EVP Andrew Polovin sold 5,398 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $402,960.70. Following the transaction, the executive vice president owned 132,056 shares in the company, valued at approximately $9,857,980.40. This represents a 3.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO James William Rogers sold 7,528 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $561,965.20. Following the completion of the transaction, the chief financial officer owned 138,473 shares in the company, valued at approximately $10,337,009.45. The trade was a 5.16% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 903,104 shares of company stock worth $63,733,330 in the last three months. Insiders own 26.27% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on TEM shares. Needham & Company LLC reiterated a "buy" rating and set a $70.00 price target on shares of Tempus AI in a research note on Friday, August 8th. Guggenheim lifted their price target on Tempus AI from $65.00 to $75.00 and gave the company a "buy" rating in a research note on Monday, June 30th. Morgan Stanley lifted their price target on Tempus AI from $65.00 to $68.00 and gave the company an "overweight" rating in a research note on Tuesday, August 12th. BTIG Research lifted their price target on Tempus AI from $75.00 to $85.00 and gave the company a "buy" rating in a research note on Wednesday, August 20th. Finally, Bank of America lifted their price target on Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research note on Wednesday, June 25th. Seven research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, Tempus AI currently has an average rating of "Moderate Buy" and an average target price of $69.50.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.